Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients-Reference-Cited by-同舟云学术

Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

Published:2003-04-07 Issue:8 Volume:100 Page:4712-4717
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Hodi F. S.,Mihm M. C.,Soiffer R. J.,Haluska F. G.,Butler M.,Seiden M. V.,Davis T.,Henry-Spires R.,MacRae S.,Willman A.,Padera R.,Jaklitsch M. T.,Shankar S.,Chen T. C.,Korman A.,Allison J. P.,Dranoff G.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference55 articles.

1. Human tumor antigens recognized by T lymphocytes.

2. New Paths in Human Cancer Serology

3. Human neoplasms elicit multiple specific immune responses in the autologous host.

4. CD4+ T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: Association with NY-ESO-1 antibody production

5. Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses

Cited by 873 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging Immune Checkpoint Inhibitors for the Treatment of Oropharyngeal Squamous Cell Carcinoma;Oral Oncology Reports;2024-09

2. Boosting immunotherapy efficacy: Empowering the Potency of Dendritic cells loaded with breast cancer lysates through CTLA-4 suppression;Heliyon;2024-09

3. Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer;Journal of Hematology & Oncology;2024-07-27

4. A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer;Clinical Cancer Research;2024-06-13

5. Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade;Advanced Drug Delivery Reviews;2024-06